.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The biotech is slashing a third of its workforce and more than half of its execu...
HHS is set to cut 10,000 jobs and consolidate divisions — have you been affected...
Human medicines European public assessment report (EPAR): Reagila, cariprazine, ...
Human medicines European public assessment report (EPAR): Pluvicto, lutetium (17...
The Food and Drug Administration will be substantially impacted, with cuts plann...
Japan faces a growing "Drug Loss" issue, but regulatory reforms and the J-ENTRY ...
Human medicines European public assessment report (EPAR): Uplizna, inebilizumab,...
Robert F. Kennedy Jr. is set to significantly cut the size of HHS, reshaping the...
Human medicines European public assessment report (EPAR): Vafseo, vadadustat, Da...
The biotech news stories you have to read, brought to you by The Readout.
The Health and Human Services Department is set to slash 10,000 jobs and streaml...
The must-read health news stories of the day.
In the first arrangement of its kind, Eli Lilly to connect patients through tele...
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept...
Fields and business rules for the European Shortages Monitoring Platform (ESMP) ...
European shortages monitoring platform (ESMP) API - Instructions to request acce...
European shortages monitoring platform (ESMP) API - Request access to ESMP API f...
European Shortages Monitoring Platform (ESMP) open Application Programming Inter...
Guidance for Rapporteurs and members of drafting groups of documents developed b...
Three year work plan for the Good Manufacturing Practice / Good Distribution Pra...
Annual report of the Good Manufacturing and Distribution Practice Inspectors Wor...
Good Manufacturing Practice (GMP) / Distribution Practice Practice (GDP) Inspect...
PIPEs were once the buzziest financing vehicle in biotech. Here's a look at how ...
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib...